4.6 Article

Moderate Long-Term Modulation of Neuropeptide Y in Hypothalamic Arcuate Nucleus Induces Energy Balance Alterations in Adult Rats

期刊

PLOS ONE
卷 6, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0022333

关键词

-

资金

  1. Portuguese Foundation for Science and Technology
  2. FEDER
  3. COMPETE [PTDC/SAU-FCF/099082/2008, PTDC/SAU-FCF/70384/2006, PTDC/SAU/NEU/73119/2006, SFRH/BD/30608/2006, SFRH/BD/29479/2006, SFRH/BPD/62945/2009, SFRH/BD/45311/2008, SFRH/BPD/49079/2008, SFRH/BPD/46086/2008, SFRH/BPD/31547/2006]
  4. Fundação para a Ciência e a Tecnologia [SFRH/BD/29479/2006, SFRH/BD/30608/2006, PTDC/SAU-FCF/099082/2008, SFRH/BD/45311/2008, SFRH/BPD/31547/2006, SFRH/BPD/46086/2008, PTDC/SAU-FCF/70384/2006, PTDC/SAU-NEU/73119/2006] Funding Source: FCT

向作者/读者索取更多资源

Neuropeptide Y (NPY) produced by arcuate nucleus (ARC) neurons has a strong orexigenic effect on target neurons. Hypothalamic NPY levels undergo wide-ranging oscillations during the circadian cycle and in response to fasting and peripheral hormones (from 0.25 to 10-fold change). The aim of the present study was to evaluate the impact of a moderate long-term modulation of NPY within the ARC neurons on food consumption, body weight gain and hypothalamic neuropeptides. We achieved a physiological overexpression (3.6-fold increase) and down-regulation (0.5-fold decrease) of NPY in the rat ARC by injection of AAV vectors expressing NPY and synthetic microRNA that target the NPY, respectively. Our work shows that a moderate overexpression of NPY was sufficient to induce diurnal over-feeding, sustained body weight gain and severe obesity in adult rats. Additionally, the circulating levels of leptin were elevated but the immunoreactivity (ir) of ARC neuropeptides was not in accordance (POMC-ir was unchanged and AGRP-ir increased), suggesting a disruption in the ability of ARC neurons to response to peripheral metabolic alterations. Furthermore, a dysfunction in adipocytes phenotype was observed in these obese rats. In addition, moderate down-regulation of NPY did not affect basal feeding or normal body weight gain but the response to food deprivation was compromised since fasting-induced hyperphagia was inhibited and fasting-induced decrease in locomotor activity was absent. These results highlight the importance of the physiological ARC NPY levels oscillations on feeding regulation, fasting response and body weight preservation, and are important for the design of therapeutic interventions for obesity that include the NPY.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Ataxin-2 in the hypothalamus at the crossroads between metabolism and clock genes

Sara Carmo-Silva, Marisa Ferreira-Marques, Clevio Nobrega, Mariana Botelho, Daniela Costa, Celia A. Aveleira, Stefan M. Pulst, Luis Pereira de Almeida, Claudia Cavadas

Summary: The ATXN2 gene is located in a trait locus for obesity and its knockout mice exhibit obesity and insulin resistance. This study shows that a high-fat diet decreases ataxin-2 levels in the hypothalamus and liver. Overexpression of ataxin-2 in the hypothalamus prevents high-fat diet-induced obesity and insulin resistance, and also rescues the circadian alterations observed in the knockout mice. These findings suggest that ataxin-2 plays a role in metabolic regulation and the circadian clock.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2023)

Article Clinical Neurology

The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors

Holger Hengel, Peter Martus, Jennifer Faber, Paola Giunit, Hector Garcia-Moreno, Nita Solanky, Thomas Klockgether, Kathrin Reetz, Bart P. van de Warrenburg, Magda M. Santana, Patrick Silva, Ines Cunha, Luis Pereira de Almeida, Dagmar Timmann, Jon Infante, Jeroen de Vries, Manuela Lima, Paula Pires, Khalaf Bushara, Heike Jacobi, Chiadi Onyike, Jeremy D. Schmahmann, Jeannette Hubener-Schmid, Matthis Synofzik, Ludger Schoels

Summary: This study reveals that non-motor symptoms such as sleep disturbance, restless legs syndrome, mild cognitive impairment, depression, bladder dysfunction, and pallhypesthesia are common among SCA3 patients and are significantly associated with disease severity and daily activities. Lifestyle factors like alcohol consumption, smoking, and physical activity may also be related to non-motor symptoms.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits

Rebekah Koppenol, Andre Conceicao, Ines T. Afonso, Ricardo Afonso-Reis, Rafael G. Costa, Sandra Tome, Diogo Teixeira, Joana Pinto da Silva, Jose Miguel Codesso, David V. C. Brito, Liliana Mendonca, Adriana Marcelo, Luis Pereira de Almeida, Carlos A. Matos, Clevio Nobrega

Summary: Koppenol et al. demonstrate that overexpression of G3BP1 reduces aggregation of ataxin-2 and ataxin-3 in cell models of SCA2 and SCA3. Lentiviral delivery of G3BP1 leads to improved motor function and neuropathology in preclinical models, suggesting its potential as a therapeutic target for polyQ disorders.
Review Biochemistry & Molecular Biology

Lipoprotein Metabolism, Protein Aggregation, and Alzheimer's Disease: A Literature Review

Elena Grao-Cruces, Carmen M. Claro-Cala, Sergio Montserrat de la Paz, Clevio Nobrega

Summary: Alzheimer's disease (AD), characterized by amyloid plaques and tau neurofibrillary tangles, is the most common form of dementia. Neuroinflammation and cellular stress have emerged as important factors in AD development and pathology. Chronic stress leads to the formation of stress granules (SGs), which have a protective role but can become pathological and neurotoxic, contributing to increased tau aggregation. Impaired lipid metabolism, specifically cholesterol efflux and lipid transport, is associated with a higher risk of AD. This review provides insight into the interplay between cellular stress, SGs, protein aggregation, and lipid metabolism in AD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biotechnology & Applied Microbiology

Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3

David Rufino-Ramos, Patricia R. Albuquerque, Kevin Leandro, Vitor Carmona, Ines M. Martins, Rita Fernandes, Carina Henriques, Diana Lobo, Rosario Faro, Rita Perfeito, Liliana S. Mendonca, Dina Pereira, Celia M. Gomes, Rui Jorge Nobre, Luis Pereira de Almeida

Summary: Machado-Joseph disease (MJD)/spinocerebellar ataxia type 3 (SCA3) is a common autosomal dominantly inherited ataxia caused by an over-repetition of the trinucleotide CAG within the ATXN3 gene. This study investigates the use of extracellular vesicles (EVs) as delivery vehicles for therapeutic miRNAs to treat MJD/SCA3. The results show that bioengineered EVs carrying miRNA-based silencing sequences effectively decrease mutant ATXN3 mRNA in cerebellar neurons and a mouse model.

MOLECULAR THERAPY (2023)

Article Clinical Neurology

A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia

Magda M. Santana, Laetitia S. Gaspar, Maria M. Pinto, Patrick Silva, Diana Adao, Dina Pereira, Joana Afonso Ribeiro, Ines Cunha, Jeannette Huebener-Schmid, Mafalda F. Raposo, Ana F. Ferreira, Jennifer Faber, Sandra Kuhs, Hector Garcia-Moreno, Kathrin Reetz, Andreas Thieme, Jon Infante, Bart P. C. van de Warrenburg, Paola Giunti, Olaf Riess, Ludger Schoels, Manuela Lima, Thomas Klockgether, Cristina Januario, Luis Pereira de Almeida

Summary: The European Spinocerebellar Ataxia Type 3/Machado-Joseph Disease Initiative (ESMI) aims to establish the largest European trial-ready cohort for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease (SCA3/MJD), a common inherited ataxia. ESMI has focused on identifying biomarkers for SCA3/MJD to facilitate future intervention studies. To ensure accurate biomarker outcomes, ESMI standardized biosampling procedures. This consensus protocol may also be applicable to other neurodegenerative disorders, particularly ataxias, and marks the first step towards protocol harmonization in this field.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Behavioral Sciences

Understanding neuron-glia crosstalk and biological clocks in insomnia

Catarina Carvalhas-Almeida, Joana Serra, Joaquim Moita, Claudia Cavadas, Ana Rita Alvaro

Summary: According to the World Health Organization, insomnia symptoms affect about one-third of the population, with chronic insomnia affecting around 10-15% of individuals. Chronic sleep deprivation and insomnia can lead to disruption in the internal synchronisation of biological clocks, resulting in negative health impacts. Glial cells, particularly microglia and astrocytes, play a role in circadian rhythm regulation and sleep/circadian regulation and overall healthy brain function. Understanding the interplay between glial cells and neurons is crucial in addressing sleep disorders and maintaining brain health.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2023)

Article Biochemistry & Molecular Biology

Selective, broad-spectrum antiviral photodynamic disinfection with dicationic imidazolyl chlorin photosensitizers

Zoe A. Arnaut, Sara M. A. Pinto, Rafael T. Aroso, Anita S. Amorim, Catarina S. Lobo, Fabio A. Schaberle, Dina Pereira, Jisette Nunez, Sandra C. C. Nunes, Alberto A. C. C. Pais, Paulo Rodrigues-Santos, Luis Pereira de Almeida, Mariette M. Pereira, Luis G. Arnaut

Summary: The COVID-19 pandemic has highlighted our vulnerability to viruses, and traditional disinfection methods and existing medicines have limitations in combating SARS-CoV-2. In this study, a new photosensitizer for antimicrobial photodynamic therapy (aPDT) was synthesized to effectively inactivate SARS-CoV-2 at low concentration and intensity without toxicity to human cells. This chlorin-based aPDT offers fast, safe, and broad-spectrum photodisinfection with low risk of resistance.

PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2023)

Article Neurosciences

SCAview: an Intuitive Visual Approach to the Integrative Analysis of Clinical Data in Spinocerebellar Ataxias

Mischa Uebachs, Philipp Wegner, Sebastian Schaaf, Simon Kugai, Heike Jacobi, Sheng-Han Kuo, Tetsuo Ashizawa, Juliane Fluck, Thomas Klockgether, Jennifer Faber

Summary: With SCAview, scientists can browse large datasets of common spinocerebellar ataxias intuitively and effortlessly. It offers various plot types to visualize data points and allows researchers to define subgroups and investigate them without technical effort.

CEREBELLUM (2023)

Review Neurosciences

Consensus Recommendations for Clinical Outcome Assessments and Registry Development in Ataxias: Ataxia Global Initiative (AGI) Working Group Expert Guidance

Thomas Klockgether, Matthis Synofzik

Summary: To accelerate and facilitate clinical trials, the Ataxia Global Initiative (AGI) was established as a worldwide research platform for trial readiness in ataxias. One of AGI's major goals is the harmonization and standardization of outcome assessments. Clinical outcome assessments (COAs) that describe or reflect how a patient feels or functions are indispensable for clinical trials, but similarly important for observational studies and in routine patient care. The AGI working group on COAs has defined a set of data including a graded catalog of COAs that are recommended as a standard for future assessment and sharing of clinical data and joint clinical studies.

CEREBELLUM (2023)

Review Geriatrics & Gerontology

The impact of insomnia on frailty and the hallmarks of aging

Catarina Carvalhas-Almeida, Claudia Cavadas, Ana Rita Alvaro

Summary: Despite age-related changes in sleep, a high percentage of older adults experience sleep dissatisfaction and chronic insomnia. Chronic insomnia, the most common sleep disorder worldwide, is expected to increase due to aging and obesity. This can lead to adverse health outcomes, promoting physical and cognitive decline and aggravating frailty in older adults. The link between chronic insomnia, hallmarks of aging, and frailty is discussed in this review, along with the potential effects of insomnia therapeutic approaches on cellular aging.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2023)

暂无数据